Readers' choice: Hot papers downloaded in 2006

Cardiovascular Research

Volumn 73, Issue 4, 2007, Pages 619-622

  Dummy, ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; EDITORIAL; MEDICAL LITERATURE; MEDICAL RESEARCH; PRIORITY JOURNAL; PUBLICATION;

BIBLIOMETRICS; CARDIOVASCULAR DISEASES; CHOICE BEHAVIOR; HUMANS; INFORMATION STORAGE AND RETRIEVAL; PERIODICALS;

EID: 33846892557     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2007.01.013     Document Type: Editorial

References (40)

1. Nagase H., Visse R., and Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 69 (2006) 562-573
2. Ushio-Fukai M. Redox signaling in angiogenesis: Role of NADPH oxidase. Cardiovasc Res 71 (2006) 226-235
3. Paravicini T.M., and Touyz R.M. Redox signaling in hypertension. Cardiovasc Res 71 (2006) 247-258
4. Geiszt M. NADPH oxidases: New kids on the block. Cardiovasc Res 71 (2006) 289-299
5. Brancaccio M., Hirsch E., Notte A., Selvetella G., Lembo G., and Tarone G. Integrin signalling: The tug-of-war in heart hypertrophy. Cardiovasc Res 70 (2006) 422-433
6. Feron O., and Balligand J.L. Caveolins and the regulation of endothelial nitric oxide synthase in the heart. Cardiovasc Res 69 (2006) 788-797
7. Hausenloy D.J., and Yellon D.M. Survival kinases in ischemic preconditioning and postconditioning. Cardiovasc Res 70 (2006) 240-253
8. Zimmermann W.H., Didie M., Doker S., Melnychenko I., Naito H., Rogge C., et al. Heart muscle engineering: An update on cardiac muscle replacement therapy. Cardiovasc Res 71 (2006) 419-429
9. Zolk O., Schenke C., and Sarikas A. The ubiquitin-proteasome system: Focus on the heart. Cardiovasc Res 70 (2006) 410-421
10. Zhao Z.Q., and Vinten-Johansen J. Postconditioning: Reduction of reperfusion-induced injury. Cardiovasc Res 70 (2006) 200-211
11. Nishikimi T., Maeda N., and Matsuoka H. The role of natriuretic peptides in cardioprotection. Cardiovasc Res 69 (2006) 318-328
12. Blanco-Colio L.M., Martin-Ventura J.L., Vivanco F., Michel J.B., Meilhac O., and Egido J. Biology of atherosclerotic plaques: What we are learning from proteomic analysis. Cardiovasc Res 72 (2006) 18-29
13. Zweier J.L., and Talukder M.A.H. The role of oxidants and free radicals in reperfusion injury. Cardiovasc Res 70 (2006) 181-190
14. Acker T., Fandrey J., and Acker H. The good, the bad and the ugly in oxygen-sensing: ROS, cytochromes and prolyl-hydroxylases. Cardiovasc Res 71 (2006) 195-207
15. Clempus R.E., and Griendling K.K. Reactive oxygen species signaling in vascular smooth muscle cells. Cardiovasc Res 71 (2006) 216-225
16. Kloner R.A., and Rezkalla S.H. Preconditioning, postconditioning and their application to clinical cardiology. Cardiovasc Res 70 (2006) 297-307
17. Newby A.C. Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates. Cardiovasc Res 69 (2006) 614-624
18. van der Harst P., Voors A.A., van Gilst W.H., Bohm M., and van Veldhuisen D.J. Statins in the treatment of chronic heart failure: biological and clinical considerations. Cardiovasc Res 71 (2006) 443-454
19. Maguy A., Hebert T.E., and Nattel S. Involvement of lipid rafts and caveolae in cardiac ion channel function. Cardiovasc Res 69 (2006) 798-807
20. Di Lisa F., and Bernardi P. Mitochondria and ischemia-reperfusion injury of the heart: fixing a hole. Cardiovasc Res 70 (2006) 191-199
21. Thum T., Fraccarollo D., Galuppo P., Tsikas D., Frantz S., Ertl G., et al. Bone marrow molecular alterations after myocardial infarction: impact on endothelial progenitor cells. Cardiovasc Res 70 (2006) 50-60
22. Rubic T., and Lorenz R.L. Downregulated CD36 and oxLDL uptake and stimulated ABCA1/G1 and cholesterol efflux as anti-atherosclerotic mechanisms of interleukin-10. Cardiovasc Res 69 (2006) 527-535
23. Mu H., Ohashi R., Yan S., Chai H., Yang H., Lin P., et al. Adipokine resistin promotes in vitro angiogenesis of human endothelial cells. Cardiovasc Res 70 (2006) 146-157
24. Jung H.S., Park K.H., Cho Y.M., Chung S.S., Cho H.J., Cho S.Y., et al. Resistin is secreted from macrophages in atheromas and promotes atherosclerosis. Cardiovasc Res 69 (2006) 76-85
25. Lim S.Y., Kim Y.S., Ahn Y., Jeong M.H., Hong M.H., Joo S.Y., et al. The effects of mesenchymal stem cells transduced with Akt in a porcine myocardial infarction model. Cardiovasc Res 70 (2006) 530-542
26. Chen Y., and Currie R.W. Small interfering RNA knocks down heat shock factor-1 (HSF-1) and exacerbates pro-inflammatory activation of NF-κB and AP-1 in vascular smooth muscle cells. Cardiovasc Res 69 (2006) 66-75
27. Zhu M., Feng J., Lucchinetti E., Fischer G., Xu L., Pedrazzini T., et al. Ischemic postconditioning protects remodeled myocardium via the PI3K-PKB/Akt reperfusion injury salvage kinase pathway. Cardiovasc Res 72 (2006) 152-162
28. Kodali R., Hajjou M., Berman A.B., Bansal M.B., Zhang S., Pan J.J., et al. Chemokines induce matrix metalloproteinase-2 through activation of epidermal growth factor receptor in arterial smooth muscle cells. Cardiovasc Res 69 (2006) 706-715
29. Spallarossa P., Altieri P., Garibaldi S., Ghigliotti G., Barisione C., Manca V., et al. Matrix metalloproteinase-2 and -9 are induced differently by doxorubicin in H9c2 cells: The role of MAP kinases and NAD(P)H oxidase. Cardiovasc Res 69 (2006) 736-745
30. Mollmann H., Nef H.M., Kostin S., von Kalle C., Pilz I., Weber M., et al. Bone marrow-derived cells contribute to infarct remodelling. Cardiovasc Res 71 (2006) 661-671
31. Li Y., Takemura G., Okada H., Miyata S., Maruyama R., Li L., et al. Reduction of inflammatory cytokine expression and oxidative damage by erythropoietin in chronic heart failure. Cardiovasc Res 71 (2006) 684-694
32. ten Freyhaus H., Huntgeburth M., Wingler K., Schnitker J., Baumer A.T., Vantler M., et al. Novel Nox inhibitor VAS2870 attenuates PDGF-dependent smooth muscle cell chemotaxis, but not proliferation. Cardiovasc Res 71 (2006) 331-341
33. Imayama I., Ichiki T., Inanaga K., Ohtsubo H., Fukuyama K., Ono H., et al. Telmisartan downregulates angiotensin II type 1 receptor through activation of peroxisome proliferator-activated receptor γ. Cardiovasc Res 72 (2006) 184-190
34. Burger D., Lei M., Geoghegan-Morphet N., Lu X., Xenocostas A., and Feng Q. Erythropoietin protects cardiomyocytes from apoptosis via up-regulation of endothelial nitric oxide synthase. Cardiovasc Res 72 (2006) 51-59
35. Wu G., Luo J., Rana J.S., Laham R., Sellke F.W., and Li J. Involvement of COX-2 in VEGF-induced angiogenesis via P38 and JNK pathways in vascular endothelial cells. Cardiovasc Res 69 (2006) 512-519
36. Smart N., Mojet M.H., Latchman D.S., Marber M.S., Duchen M.R., and Heads R.J. IL-6 induces PI 3-kinase and nitric oxide-dependent protection and preserves mitochondrial function in cardiomyocytes. Cardiovasc Res 69 (2006) 164-177
37. 2+ depletion induces endothelial cell apoptosis independently of caspase-12. Cardiovasc Res 69 (2006) 908-915
38. Hassouna A., Loubani M., Matata B.M., Fowler A., Standen N.B., and Galinanes M. Mitochondrial dysfunction as the cause of the failure to precondition the diabetic human myocardium. Cardiovasc Res 69 (2006) 450-458
39. Sarr M., Chataigneau M., Martins S., Schott C., El Bedoui J., Oak M.H., Muller B., et al. Red wine polyphenols prevent angiotensin II-induced hypertension and endothelial dysfunction in rats: Role of NADPH oxidase. Cardiovasc Res 71 (2006) 794-802
40. Bopassa J.C., Ferrera R., Gateau-Roesch O., Couture-Lepetit E., and Ovize M. PI 3-kinase regulates the mitochondrial transition pore in controlled reperfusion and postconditioning. Cardiovasc Res 69 (2006) 178-185